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The Nociception Coma Scale-Revised (NCS-R) was developed to help assessing pain in patients 
with disorders of consciousness (DOC). Several studies have shown its sensitivity in assessing 
responses to acute noxious stimuli. However, they failed to determine a reliable cut-off score that 
could be used to infer pain processing in these patients. 
This retrospective cross-sectional study aimed to determine an NCS-R cut-off score supporting 
preserved neural basis for pain experience, based on brain metabolism as measured by 
fluorodeoxyglucose positron emission tomography (FDG-PET).  
We included patient with unresponsive wakefulness syndrome confirmed by the FDG-PET 
(UWS) and looked at their highest NCS-R total scores. As the highest score was 4, we 
determined the cut-off of 5 and compared the brain metabolism of these patients with matched 
patients with DOC and with a cut-off score ≥ 5 (i.e., potential pain) and healthy subjects.  
We found a higher global cerebral metabolism in healthy subjects compared with both patients’ 
groups and also in patients with potential pain compared with FDG-PET confirmed UWS. We 
observed a preserved metabolism in the left insula and a preservation of the connectivity between 
the left insula and the medial frontal gyrus in patients with potential pain compared with FDG-
PET confirmed UWS.  
 
Perspectives: Our data suggest that using the cut-off score of 5 can be helpful to improve pain 
management in patients with DOC. Future studies should focus on patients showing scores 
below this cut-off to better characterize their profile and improve cares.  
 







Abbreviations: CRS-R = Coma Recovery Scale Revised, NCS-R = Nociception Coma Scale 
Revised, DOC = Disorders of Consciousness, UWS = Unresponsive Wakefulness Syndrome, 
MCS = Minimally Conscious State, MCS* = UWS with atypical cortical metabolism 




Assessing and treating pain in severely brain-injured patients unable to communicate is a real 
challenge. Cases like unresponsive wakefulness syndrome (UWS; eye opening periods and only 
reflexive movements [25,33]) and minimally conscious state (MCS; purposeful responses without 
functional communication [13,25]) bring major ethical and clinical concerns regarding their need 
for pain treatment. Neuroimaging studies have investigated cortical responses to noxious stimuli 
in UWS and MCS patients. These studies reported a preservation of thalamo-cortical 
connectivity and an activation of areas involved in the cognitivo-affective dimension of pain 
(insula, anterior cingulate cortex [ACC]) in MCS patients that seem to be impaired in UWS 
patients [2,17,19]. However, other neuroimaging data reported remaining activity within the 
emotional pain network in about 30% of in UWS patients [21], suggesting that residual sensory 
and emotional pain processing can remain active even if the patient is unresponsive at bedside. 
Among the different techniques used to better document the patient’s covert abilities, 18F- 
fluorodeoxyglucose positron emission tomography (FDG-PET) has been shown to be a strong 
complement to bedside examinations for patients with disorders of consciousness (DOC) [28–
30,34]. A study about diagnostic precision of FDG-PET reported that 32 % of the behaviorally 
UWS patients showed signs of potential covert cognitive abilities, and 69% of them recovered 
signs of consciousness after 12 months [28]. Moreover, global metabolic rate of glucose have 
shown a good sensibility (95%, [30])  to distinguish UWS from MCS . 
The Nociception Coma Scale-Revised (NCS-R) was developed to assess potential pain in 
patients with DOC [4,6,27]. Several studies have shown its sensitivity to nociception and to the 
level of consciousness [6,27]. A study using FDG-PET reported a significant correlation between 
NCS-R total scores and resting brain metabolism in the ACC [7], supporting that the higher the 
score, the higher the potential for cortical pain processing. If previous results support the 
experimental and clinical usefulness of this tool, there is currently no reliable cut-off score that 
has been defined to determine the potential experience of pain and the need for treatment [5,6].  
The aim of this study was to determine an NCS-R cut-off score using an approach based on 
neuroimaging data. Using FDG-PET, we investigated the NCS-R score ranges obtained in 
“FDG-PET confirmed UWS patients”. The diagnosis was based on behavioral assessment and 
visual examination of brain metabolism (i.e., a severe bilateral hypometabolism of the 
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associative frontoparietal cortex without preserved areas led to a diagnostic of UWS [28]). We 
hypothesize that patients with a global hypometabolism of the whole cortical area (including the 
network known to be involved in pain processing) cannot sustain conscious treatment of 
potentially painful stimuli. Therefore the highest behavioral responses observed in these FDG-
PET confirmed UWS patients could be used as a conservative NCS-R cut-off score [6,28,30]. 
Then, we looked at the global and local differences in brain metabolism between FDG-PET 
confirmed UWS, patients with potential pain (i.e., patients with a NCS-R score equal or higher to 
the threshold defined in the study) and healthy subjects, all matched for age, gender, and 
etiology. We hypothesize that patients with perception of pain would have a minimal cortical 
preservation, particularly in areas involved in pain processing (i.e., ACC and insula [2]), as 
compared with patient without perception of pain. As pain processing requires also a 
preservation of cortical connectivity, we investigated differences in cortical connectivity in FDG-




This retrospective study included patients admitted to the intensive care and the neurology ward 
of the University Hospital of Liège. These patients were assessed as part of a week of diagnostic 
and prognostic assessment. Inclusion criteria were: (1) age ≥ 16 years, (2) no administration of 
neuromuscular function blockers and no sedation 24 h before assessment, (3) a diagnosis of 
unresponsive wakefulness syndrome (UWS) or minimally conscious state (MCS), based on the 
behavioral assessment performed using the Coma Recovery Scale-Revised (CRS-R [14]), (4) 
pain assessment performed with the NCS-R, and (5) brain metabolism data assessed by FDG-
PET. Exclusion criteria were: (1) documented history of prior brain injury; (2) premorbid history 
of developmental, psychiatric or neurologic illness resulting in documented functional disability 
up to time of the injury; and (3) upper limb contusions, fractures or flaccid paralysis. The study 
was approved by the Ethics Committee of the Faculty of Medicine of the University of Liege and 




For PET analyses, inclusion criteria for the healthy subjects were: (1) no history of neurologic or 
psychiatric disorders, (2) no head injuries, (3) absence of pregnancy, (4) absence of diabetes.  
Different groups were used during this study, criteria of each group were:  
- “FDG-PET confirmed UWS” group: (1) patients behaviorally diagnosed as UWS (2) 
with a global decrease of brain metabolism on FDG-PET based on visual examination of 
the  FDG-PET Standardized Uptake Values (see below [28]).  
- “Patients with potential pain” group: (1) patients behaviorally diagnosed as UWS or MCS 
with (2) a pain assessment performed by the NCS-R with a score equal or higher to the 
threshold defined before.  
 
Materials: 
We included data obtained with the NCS-R following experimental noxious stimulation (deep 
pressure on the left and right nailbed of the middle finger for 5 seconds [27]) The use of finger 
pressure as a noxious stimulation was used as it is widely used in different neurobehavioral 
scales to assess response to nociception [14,32]. To ensure we captured the highest response of 
the patient, we also looked at the NCS-R scores during mobilization. If mobilizations are not 
comparable to an experimental noxious stimulus, several studies reported that mobilizations (i.e., 
care or physiotherapy) could be potentially painful for patients with brain injury [11,12]. The 
NCS-R includes three subscales, each of them graded from 0 to 3, assessing motor, verbal, and 
facial expression with a total score ranging from 0 to 9.  
 
The CRS-R was used to determine the clinical diagnosis of the patient. It consists of 23 
hierarchically arranged items that comprise six subscales addressing arousal, auditory, visual, 
motor, oromotor/verbal and communication functions. The lowest item on each subscale 
represents reflexive activity while the highest item represents cognitively-mediated behaviors 
[14]. The assessment was performed at least 5 times during the same week (between day 1 and 
day 5) by different examiners to reduce the potential misdiagnosis [37] and the best diagnosis 




Positron emission tomography was performed during resting conditions after intravenous 
injection of 5 to 10 mCi (185-370 MBq) FDG on a Gemini Big Bore PET/CT scanner (Philips 
Medical Systems, Best, Netherlands). Data were spatially normalized to a stereotaxic space and 
smoothed using a 14 mm full width at half maximum Gaussian kernel. To overcome the problem 
of big deformations due to brain lesions as well as the fact that SPM has a default template based 
on H152O data, the normalization was performed using a customized template using the 
procedure as described in [24]. Statistical analyses were performed using Statistical Parametric 
Mapping (SPM12; www. fil.ion.ucl.ac.uk/spm). The FDG-PET and the NCS-R assessment were 
performed the same day. 
 
Determining the cut-off score 
We used the FDG-PET Standardized Uptake Values (SUV) to assess the cerebral metabolic rate 
of glucose consumption: 𝑆𝑈𝑉 =  
(𝐷𝑒𝑐𝑎𝑦 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑉𝑜𝑥𝑒𝑙 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦)
𝐼𝑛𝑗𝑒𝑐𝑡𝑒𝑑 𝐷𝑜𝑠𝑒
𝐵𝑜𝑑𝑦 𝑊𝑒𝑖𝑔ℎ𝑡
 at single subject level. The SUV 
images were used to select FDG-PET confirmed UWS patients through visual observation by 
three different expert examiners (all blinded of the clinical diagnosis and other examiners 
assessment). Each expert (neuropsychologist and physiotherapist working with patients with 
DOC and PET imaging for at least 5 years) provided a diagnosis based on two illustrative 
examples of UWS and MCS (see Figure 1). Full agreement was observed for typical UWS. 
Then, we looked at the NCS-R highest score in this subgroup of FDG-PET confirmed UWS to 
determine the cut-off score.  
 
<<Insert Figure 1 around here >> 
 
Brain metabolism and cut-off score 
To investigate whether the cut-off score can be used to support preserved neural basis for pain 
experience, we used global and regional brain preservation. A group of patients with DOC and 
potential pain was selected based on their age, gender and etiology (diagnosis of UWS or MCS) 
to match with the FDG-PET confirmed UWS patients. A group of healthy subjects (also matched 
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for age and gender) was also included. We extracted the global mean value to compare global 
brain metabolism preservation between the three groups. 
To look for regional differences, we used a design matrix including the FDG PET confirmed 
UWS patient, patients with potential pain, and the healthy subjects’ scans. We identified brain 
regions with preserved metabolism in patients with potential pain vs FDG PET confirmed UWS 
patients and in patients with potential pain vs healthy subjects. We also identified brain regions 
with decreased metabolism in patients with potential pain vs healthy subjects and in FDG-PET 
confirmed UWS patients vs healthy subjects. Global normalization was performed by 
proportional scaling. Thresholding of results was done at p < .05 corrected for multiple 
comparisons within a priori defined regions of interest (using a 10-mm radius spherical small 
volume correction in SPM—at voxel and cluster level) centered on a priori coordinates for areas 
previously identified as the most frequently identified in pain processing (i.e., ACC and bilateral 
insula; respective coordinates x = 12, y = 10, z =36; x = −34, y = −24, z = 36; and x = 34, y = 
−24, z = 36, were taken from two previous studies on pain perception [2,7]). 
 
Cortical connectivity  
Then, we used a psychophysiological interaction analysis to observe the cortical connectivity in 
patients with potential pain and in FDG-PET confirmed UWS patient [10]. The design matrix 
included the same scans as described above and considered group differences in mean levels of 
glucose consumption. Now the analysis looked for brain regions that experienced a significant 
difference in reciprocal modulation with/from the cortical regions most preserved in patients 
with potential pain. It included the most significant peaks obtained from the first analysis. 
A posteriori, we looked at regional brain metabolism preservation in patients MCS* (i.e., 
behaviorally diagnosed in UWS but with an atypical cortical metabolism preservation [15] who 
showed potential pain (i.e., a score ≥ cut-off) at the single subject level, using the same approach 
as described above (compared with 33 healthy subjects, 18 men, mean age 43, SD 15 years).  
Finally, we calculated the sensitivity (i.e., proportion of patients who have received noxious 
stimulation and have a NCS-R score equal or above the threshold defined in the study) and 
specificity (i.e., proportion of patients who have not received noxious stimulation and have a 
NCS-R score below the threshold) of the threshold defined for all the patients with MCS 
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assessed with the NCS-R since 2011 in order to assess the number of patients who might be 
underestimated by the identified threshold. 
 
Results: 
Out of the 209 patients included in the database, 50 patients were diagnosed in UWS with the 
CRS-R assessment. Out of these 50 patients, 26 showed a global cortical hypometabolism based 
on visual analysis (i.e., “FDG-PET confirmed UWS”, see Figure 1 and 2) and 13 of these FDG-
PET confirmed UWS patients were assessed with the NCS-R.  
 
Determining the cut-off score 
When looking at the range of NCS-R total scores for these 13 FDG PET confirmed UWS 
patients (8 men, range of age: 27-73 years, aetiology: traumatic (n=1), post-anoxic (n=7), 
subarachnoid hemorrhage (n=1), stroke (n=2) and mixed etiology (n=2), see Supplementary 
Table 1) found scores between 0 and 4 during potentially painful conditions (i.e., noxious 
stimulation and/or mobilisation). Therefore, we set the cut-off score at ≥ 5.  
 
<<Insert Figure 2 around here >> 
 
Brain metabolism and cut-off score 
In a second step, these 13 FDG-PET confirmed UWS were matched with 13 patients with DOC 
presenting a potential pain (i.e., NCS-R score ≥ 5; see Supplementary Table 1) and 13 healthy 
subjects (18 men, mean age 43, SD 15 years). Out of the 13 patients with potential pain, 3 were 
unresponsive at bedside (i.e., MCS* = UWS with atypical cortical metabolism preservation [15]). 
The data were not normally distributed according to Shapiro-Wilk tests (W < 1, p = 0.012). A 
non-parametrical statistical analysis was performed using a Kruskal-Wallis test in order to 
compare global metabolism in FDG-PET confirmed UWS vs patient with potential pain vs 
healthy subjects. We found a higher global metabolism in healthy subjects compared to both 
patients’ group (χ2 = 33.8; df = 2; p < .0001), and in patients with potential pain compared to 
FDG-PET confirmed UWS (χ2 = 33.8; df = 2; p<.0001; see Figure 3).  
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Locally, we observed a preservation in brain metabolism only in the left insula in patients with 
potential pain compared to FDG-PET confirmed UWS (Z= 3.31; corrected p= 0.016; MNI 
[Montreal Neurological Institute] coordinates x = -38, y = -20, z = 44; see Figure 3). This 
preservation was also observed in patient with potential pain when compared to healthy subjects 
(Z= 5.95; corrected p= 0.004; MNI coordinates x = -32, y = -32, z = 40). We did not observed a 
preservation in brain metabolism in the right insula. 
<<Insert Figure 3 around here >> 
 
A hypometabolism in the ACC was observed in FDG-PET confirmed UWS patients (Z= 5.06; 
corrected p= 0.011; MNI coordinates x = 6, y = 18, z = 36) compared to healthy subjects and 
between patients with potential pain and healthy subjects (Z= 4.01; corrected p= 0.012; MNI 
coordinates x = 4, y = 14, z = 32). 
 
Cortical connectivity 
A preservation of the connectivity between the left insula (MNI coordinates x = -38, y = -20, z = 
44) and the medial frontal gyrus (Z= 5.06; corrected p= 0.011; MNI coordinates x = 6, y = 18, z 
= 36, see Figure 4) was observed in patients with potential pain as compared with FDG-PET 
confirmed UWS patients. 
<<Insert Figure 4 around here >> 
 
When focusing on the three MCS* showing a score ≥ 5, we observed a preservation in brain 
metabolism in the insula bilaterally in all 3 patients, and in the ACC in 2 patients (see Figure 4 
and 5). 
<<Insert Figure 5 around here >> 
 
Finally, when accounting for all patients with MCS assessed with the NCS-R during an 
experimental noxious stimulation (n=65), we found a specificity of 98.46 % (n=64) and a 
sensitivity of 23.07 % (n=15) for detecting potential pain in this population.  
11 
 
 Discussion:  
The aim of this retrospective study was to determine a cut-off score at the NCS-R supporting 
preserved neural basis for pain experience, based on global and local brain metabolic activity.  
First, we investigated the NCS-R score ranges obtained in FDG-PET confirmed UWS patients 
(i.e., patients with critically low cortical metabolic activity, no access to consciousness and 
therefore no access to conscious process of pain). According to our results, the highest 
behavioral responses observed during noxious stimulation and mobilization was associated with 
a NCS-R total score of 4. In other words, those results suggest that a score equal to or above 5 
would require a certain degree of cortical processing of painful stimuli and a potential experience 
of pain. Therefore, we fixed the conservative NCS-R cut-off score at 5, suggesting that careful 
attention should be given to treat with analgesics patients with score equal or higher to 5.   
As a second step, we compared the global brain metabolism between the FDG-PET confirmed 
UWS, patients with potential pain and healthy subjects. Patients with potential pain showed a 
significantly higher global metabolism than the FDG-PET confirmed UWS group. It goes in line 
with previous findings on reduced metabolism in UWS as compared with MCS [30].  
As a third step, we looked at regional differences in brain metabolism in two areas known to be 
involved in pain processing, namely the insula (1) and the ACC (2). 
(1) In the insula, we found a preservation only in the left insula in patients with potential pain 
compared to patients with FDG-PET confirmed UWS and healthy subjects [29]. Studies 
have suggested that this region could be involved in the affective dimension of pain by 
playing a mediating role between its posterior part (lateral system) and the rostral part of 
the ACC (median system) [8,23]. If some studies support a higher involvement of the 
right hemisphere in pain sensation [22,36], several of them have also shown a bilateral 
activation of the insula during a noxious stimulation [3,31].  
(2) In the ACCs, however, a hypometabolism of the ACC was also observed in patients with 
potential pain and patients in UWS when compared to healthy subjects. In neuroimaging 
studies on pain processing, the ACC is one of the most frequent region to come up as 
being linked to pain. This region, most particularly the rostral part of the ACC, seems to 
be key for the affective dimension of pain processing [29,38]. Neuroimaging studies have 
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shown that the increase of brain activity in the ACC was correlated with an increased 
pain sensation [16,26]. Other studies demonstrated an activation of this region after a 
noxious stimulation in patients with MCS but also in some patients with UWS [1,2]. 
Then, we wanted to investigate and compare the cortical connectivity in patients with potential 
pain and in FDG-PET confirmed UWS patients. We found a preservation of the connectivity 
between the left insula and the medial frontal gyrus in patients with potential pain but not in 
FDG-PET confirmed UWS patients supporting that the threshold of 5 could be used for inferring 
preserved neural basis for pain experience [2,19].  
If one could say that these results are mainly due to the MCS patients included in the group (i.e., 
higher brain metabolism in MCS than UWS [30]), single subject analysis of the 3 MCS* patients 
with potential pain supports the idea that these patients also had a preserved brain metabolism in 
areas involved in pain processing (i.e., ACC and insula). This also suggests that the score of 5 or 
higher could be used as a red flag for pain processing, even in patients behaviorally diagnosed in 
UWS, and by extension the presence of covert cognitive abilities in these patients [17].  
Our approach justifies its origin in the fact that previous studies aiming at determining NCS-R 
cut-off scores failed in distinguishing reliably behavioral responses that could be elicited by non-
noxious vs noxious stimulations [5,6]. In fact, a recent study [5] determined a cut-off score of 2, 
a total score that could be achieved only by purely reflexive/spinally-mediated behavior and that 
would inevitably lead to a large amount of false positive patients. Nevertheless, we are aware 
that our threshold of 5, despite its significant advantage to be specific for a cortical process of 
pain and usable independently of the clinical diagnosis of the patient, has the disadvantage, as we 
will discuss later on, to lead to a large lack of sensitivity.  
These findings need to be interpreted in spite of several limitations: (1) the heterogeneity of the 
population (i.e., etiology : more anoxic patients in UWS than in MCS), time since injury); (2) 
this study is retrospective, so it was difficult to control for confounding factors such as 
pharmacological treatment, motor abilities, intensity of the noxious stimulation or heterogeneity 
in threshold for pain in each patient; (3) the use of neuroimaging in patient with severe brain 
damages targeting regions of interest may be challenging but also can be of limited interpretation 
due to normalization and smoothing issues; (4) we only had the opportunity to analyze resting 
state brain metabolism data, which is less sensitive and relevant than activation studies when 
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discussing about pain processing and could also account for differences with some previously 
mentioned studies. One could also argue that one of the conditions used may not be nociceptive 
(i.e., mobilization). However, our aim was to first determine the highest score that could be 
observed in FDG-PET confirmed UWS, and as mobilization can be potentially painful 
(especially in this population suffering from various physical pathologies such as spasticity [35]), 
we think it is relevant to use such data in this study. The fact that some of the patients included 
showed higher scores during mobilization than during experimental pain supports our approach. 
Despite these limitations, behavioral (i.e., cut-off score ≥ 5) and neuroimaging results (i.e., 
higher global brain metabolism and better preservation of the metabolism in the left insula) 
suggest that patients with a NCS-R score ≥ 5 are potentially able to perceive pain, or have, at 
least, the neural basis for experiencing it. However, this cut-off score needs to be interpreted with 
caution given its low sensitivity while being highly specific. Indeed, 74 % of patient with MCS 
displayed a score below this threshold following an experimental noxious procedure. If part of 
them could have an impairment in pain processing, it is also likely that for others the NCS-R 
could have failed to detect potential painful stimuli due to patients’ motor issue.  
In conclusion, this retrospective study allowed (1) to determine a cut-off score of 5 at the NCS-R 
that allows to identify patients with preserved neural basis for pain processing and which is in 
relation with a better preservation of global and local (left insula and ACC) cerebral metabolism 
and (2) to suggest that, at least, the preservation of the left insula and the left ACC are 
prerequisites to the conscious process of pain, supporting our hypothesis whereby behavioral 
responsiveness to pain necessitates a minimal preservation in regions involved in pain processing 
in patients with DOC. These data provide a first step towards providing better guidelines to 
clinicians for the management of pain in DOC. The very high specificity and low sensitivity of 
the score highlight the score currently proposed is very conservative and, if patients with a score 
of 5 or more should clearly be targeted as potentially in pain, it also shows that patients with a 
score below that threshold may still be in pain and in need of an appropriate treatment and 
should not be neglected. 
Finally, this study also highlights the complex relationship between consciousness and pain 
processing. The use of the NCS-R in a clinical setting becomes clearer as we can now support 
that patients with a NCS-R score below 2 are not able to perceive a stimulus as being painful and 
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that, on the other side, patients who show a score of 5 or above are likely able to perceive a 
stimulus as painful. Future studies should focus on better characterizing pain processing in 
patients with a NCS-R score between 2 and 5, and develop non-behavioral/paraclinical 
biomarkers of pain processing in DOC.  
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Figure Legends: 
Figure 1: Brain metabolism at PET-FDG in a) unresponsive patient (UWS) with a global 
hypometabolism, b) patient in minimally conscious state (MCS) and c) healthy control. The scale 
represents the cerebral metabolic rate of glucose (CMRglc; μmoL/g per minute) from 0 (blue) to  
12 (red). 
 
Figure 2: Flow chart representing the selection of patients in a) UWS with the CRS-R 
assessment and with a global hypometabolism at PET-FDG, b) MCS with potential pain defined 
based on threshold (LIS = Locked-in syndrom, eMCS = emergency minimally conscious state, 
UWS = Unresponsive wakefulness syndrom/vegetative state, MCS* = UWS with atypical 
cortical metabolism preservation).  
 
Figure 2: Left: Global brain metabolism preservation in FDG-PET confirmed 
unresponsive patients (UWS) with NCS-R score < 5, patients with disorders of 
consciousness (DOC) with NCS-R score ≥ 5 and healthy subjects (CTRL; grey triangles 
represent patients behaviorally diagnosed as UWS). Right: Regional brain metabolism 
preservation in patients with a NCS-R score ≥ 5 compared to FDG-PET confirmed UWS. 





Figure 4: Brain metabolism in the left insula (x = -55mm, y = -20 mm, z = 12 mm) and in 
medial frontal gyrus (x = 6mm; y = -18mm; z = 56mm; right panel) in patients with 
disorders of consciousness (DOC) with NCS-R score ≥ 5 (grey dots) compared to well 
documented unresponsive patients (UWS) with NCS-R score < 5 (black dots).  
 
Figure 5: Coordinates of peak voxels (in standardized stereotaxic MNI space) showing 
preserved and impaired metabolism in patients behaviorally UWS with a NCS-R score ≥ 5 
(MCS*) compared to healthy subjects (using a 10-mm radius spherical small volume 
correction in SPM—at voxel and cluster level, centred on a priori coordinates for areas 
previously identified as the most frequently identified in pain processing; i.e., ACC and bilateral 
insula; respective coordinates x = 12, y = 10, z =36; x = −34, y = −24, z = 36; and x = 34, y = 
−24, z = 36). P value corrected for multiple comparisons at cluster level. 
 
Supplementary Table 1 : Demographic table of patients in UWS with the CRS-R 
assessment and with a global hypometabolism at PET-FDG, based on visual inspection and 
matched patients with NCS-R score ≥ 5. (F = Female, M = Male, TBI = Traumatic Brain 
Injury, SAH = Subarachnoid hemorrhage, UWS = Unresponsive Wakefulness Syndrome, MCS 
= Minimally Conscious State, MCS* = behaviorally UWS with atypical brain metabolism on 
FDG-PET. In red = highest score observed during the NCS-R). 
Supplementary Figure 1 : PET-FDG showing the brain activation in the 13 well-
documented UWS selected for the study. (MCS = Minimally Conscious State, CTRL = healthy 
subjects). 
 
 
 
